We are experts in supporting Pharma in a smooth exit from current commercial markets, through the seamless transition to a Market Withdrawal Program
Market withdrawals involve assisting pharmaceutical companies in maintaining patient access to a medicine in a specific market after withdrawing their products.
The aim is to ensure a smooth and secure transition for patients to continue treatment once the Marketing Authorization has been withdrawn.
In certain situations pharmaceutical companies might opt to remove a medicine from a market due to diverse business considerations, even if there are some patients who may still benefit from the medication. The choice to remove the Marketing Authorization can be intricate due to the possible negative consequences on patients and the company’s image.
Depending on the specific product and market, it can be feasible to continue access in the market following withdrawal by implementing methods utilizing named patient pathways. Inceptua supports pharmaceutical companies in managing the withdrawal by establishing a compliant solution to maintaining access.
Why Inceptua:
1. One single, trusted partner for the reliable and compliant provision of medicines into territories where it is no longer commercially available
2. Asset-specific Program Strategy – Successful programs (300+ programs) devised through deep Early Access and Commercial Pharma experience to develop Program strategies to synergize with your strategic decisions
3. Global Competence – Global coverage for your program in more than 120 markets worldwide, with deep experience in complex markets
4. Industry Thought-Leaders – Pioneering team in the Early Access world, having developed industry standard services means you receive industry-best guidance, adapting to external developments in real-time to ensure optimal program performance
Ask our experts
About
About
About
About
